 |
Video: What is a Stock Split?
|
 |
Outset Medical, Inc. is a medical technology company. Co. offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. Co. designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by virtually anyone. The Tablo system comprises components, which include Tablo Console, Tablo Cartridge and Tablo Data Ecosystem. According to our OM split history records, Outset Medical has had 1 split. | |
 |

Outset Medical (OM) has 1 split in our OM split history database. The split for OM took place on March 20, 2025. This was a 1 for 15 reverse split, meaning for each 15 shares of OM owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split.
When a company such as Outset Medical conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the OM split history from start to finish, an original position size of 1000 shares would have turned into 66.6666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Outset Medical shares, starting with a $10,000 purchase of OM, presented on a split-history-adjusted basis factoring in the complete OM split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
09/16/2020 |
|
End date: |
07/17/2025 |
|
Start price/share: |
$900.45 |
|
End price/share: |
$17.60 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-98.05% |
|
Average Annual Total Return: |
-55.68% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$195.48 |
|
Years: |
4.84 |
|
|
 |
Date |
Ratio |
03/20/2025 | 1 for 15 |
|
 |